Literature DB >> 20429016

A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life.

D Deans Buchanan1, Frances J MacIvor.   

Abstract

BACKGROUND: Systemic administration of lidocaine has been widely reported to provide effective analgesia in both cancer and non-malignant pain. CASE REPORT: We report the use of intravenous lidocaine in the management of cancer-related neuropathic pain and its pivotal role in restoring function and facilitating end-of-life care at home.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20429016     DOI： 10.1007/s00520-010-0864-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  10 in total

1.  How to initiate and monitor infusional lidocaine for severe and/or neuropathic pain.

Authors:  Rebecca Ferrini; Judith A Paice
Journal:  J Support Oncol       Date:  2004 Jan-Feb

2.  Lidocaine intoxication at very small doses in terminally ill cancer patients.

Authors:  Yo Tei; Tatsuya Morita; Hideki Shishido; Satoshi Inoue
Journal:  J Pain Symptom Manage       Date:  2005-07       Impact factor: 3.612

Review 3.  Mechanisms of analgesia of intravenous lidocaine.

Authors:  Gabriela Rocha Lauretti
Journal:  Rev Bras Anestesiol       Date:  2008 May-Jun       Impact factor: 0.964

4.  What is the mechanism underlying treatment of pain by systemic application of lidocaine?

Authors:  Wilfrid Jänig
Journal:  Pain       Date:  2008-05-01       Impact factor: 6.961

Review 5.  Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis.

Authors:  Ivo W Tremont-Lukats; Vidya Challapalli; Ewan D McNicol; Joseph Lau; Daniel B Carr
Journal:  Anesth Analg       Date:  2005-12       Impact factor: 5.108

6.  Intravenous lidocaine relieves severe pain: results of an inpatient hospice chart review.

Authors:  Jay Thomas; Robert Kronenberg; Michael Craig Cox; Gilbert C Naco; Mark Wallace; Charles F von Gunten
Journal:  J Palliat Med       Date:  2004-10       Impact factor: 2.947

Review 7.  Systemic lidocaine for neuropathic pain relief.

Authors:  Jianren Mao; Lucy L Chen
Journal:  Pain       Date:  2000-07       Impact factor: 6.961

Review 8.  Intravenous lidocaine: an outdated or underutilized treatment for pain?

Authors:  Gary McCleane
Journal:  J Palliat Med       Date:  2007-06       Impact factor: 2.947

9.  A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients.

Authors:  Shekhar Sharma; M R Rajagopal; Gayatri Palat; Charu Singh; Altaf G Haji; Dimpel Jain
Journal:  J Pain Symptom Manage       Date:  2008-07-02       Impact factor: 3.612

10.  Subcutaneous lidocaine for treatment of neuropathic cancer pain.

Authors:  William G Brose; Micheal J Cousins
Journal:  Pain       Date:  1991-05       Impact factor: 6.961
  10 in total
  3 in total

1.  Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2011-01

2.  Lidocaine Infusion: A Promising Therapeutic Approach for Chronic Pain.

Authors:  Enas Kandil; Emily Melikman; Bryon Adinoff
Journal:  J Anesth Clin Res       Date:  2017-01-11

3.  Parenteral Lidocaine for Complex Cancer Pain in the Home or Inpatient Hospice Setting: A Review and Synthesis of the Evidence.

Authors:  Poh Heng Chong; Zhi Zheng Yeo
Journal:  J Palliat Med       Date:  2020-12-22       Impact factor: 2.947
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.